Transmural Biotech
Transmural Biotech is a leading global biotechnology company specializing in innovative medical technologies based on image analysis and artificial intelligence. Founded as a spin-off from Hospital Clinic of Barcelona and the University of Barcelona, it develops non-invasive, personalized, economical, and efficient diagnostic tests for various medical fields including maternal-fetal, oncology, neurodegenerative, and cardiovascular diseases. Their product suite includes AI-driven diagnostic tests such as quantusFLM for fetal lung maturity, quantusPREMATURITY for preterm birth risk, quantusSKIN for skin lesion malignancy, quantusGL for glaucoma detection, and quantusMM for early breast pathology detection. The company operates a web-based platform for rapid, reliable test results and has a strong international distribution network, including significant presence in Latin America, North America, Europe, and Asia. Transmural Biotech is recognized among the top 20 most innovative biotech companies worldwide and has received multiple prestigious awards for digital medicine innovation. Their main partner is Grupo Asisa, a major Spanish health conglomerate, supporting their global expansion and commitment to quality healthcare through advanced technology.
Transmural Biotech
Transmural Biotech is a leading global biotechnology company specializing in innovative medical technologies based on image analysis and artificial intelligence. Founded as a spin-off from Hospital Clinic of Barcelona and the University of Barcelona, it develops non-invasive, personalized, economical, and efficient diagnostic tests for various medical fields including maternal-fetal, oncology, neurodegenerative, and cardiovascular diseases. Their product suite includes AI-driven diagnostic tests such as quantusFLM for fetal lung maturity, quantusPREMATURITY for preterm birth risk, quantusSKIN for skin lesion malignancy, quantusGL for glaucoma detection, and quantusMM for early breast pathology detection. The company operates a web-based platform for rapid, reliable test results and has a strong international distribution network, including significant presence in Latin America, North America, Europe, and Asia. Transmural Biotech is recognized among the top 20 most innovative biotech companies worldwide and has received multiple prestigious awards for digital medicine innovation. Their main partner is Grupo Asisa, a major Spanish health conglomerate, supporting their global expansion and commitment to quality healthcare through advanced technology.